Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Pharming Group N.V. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 25.9K | 20.5K | −5.42K (−20.9%) |
| Value | $295.6K | $234.4K | −$61.2K (−20.7%) |
New holders (1)
Institutions that held Pharming Group N.V. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | 17,710 | $202.4K | 0.19% |
Sold out (2)
Institutions that held Pharming Group N.V. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Brinker Capital Investments, LLC | 11,715 | $133.6K |
| Orion Portfolio Solutions, LLC | 11,715 | $133.6K |